Clolar Related Clinical Trials
Clofarabine vs Clofarabine in Plus With Low-Dose Ara-C in Previously Untreated Patients With AML and High-Risk MDS. [Completed]
A Study of Clofarabine for Older Patients With Newly Diagnosed Acute Myelogenous Leukemia (AML) (CLASSIC II) [Active, not recruiting]
Study of Oral Clofarabine Administered Daily for 5 Days in Adult Patients With Refractory Solid Tumors [Completed]
Clofarabine and AraC for the Treatment of AML, MDS [Active, not recruiting]
Clofarabine in Adult Patients With Advanced Solid Tumors [Completed]
Allogeneic Stem Cell Transplant With Clofarabine, Ara-C and TBI for AML and ALL [Recruiting]
Clofarabine Combinations in Relapsed/Refractory AML, MDS and Myeloid Blast Phase CML [Recruiting]
A Dose Confirmation Study of Oral Clofarabine for Previously Treated Adult Patients With Intermediate-2 or High Risk Myelodysplastic Syndromes (MDS) [Recruiting]
Low-Dose Oral Clofarabine for the Treatment of IPSS INT-1, INT-2 or HIGH Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia [Recruiting]
Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Following an Allogeneic Stem Cell Transplant [Recruiting]
Study of Weekly Clofarabine for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia [Active, not recruiting]
2 Arm Study of Clofarabine IV in MDS Patients [Recruiting]
Oral Clofarabine for Acute Myeloid Leukemia (AML) Patients 60 Years and Older [Not yet recruiting]
Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphomas [Recruiting]
Clofarabine for Myelodysplastic Syndrome (MDS) Patients Who Failed Vidaza Treatment (tx) [Recruiting]
Oral Clofarabine Study in Patients With Myelodysplastic Syndrome [Recruiting]
Clofarabine and Non-Myeloablative Allogeneic Hematopoietic Transplantation [Recruiting]
Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline AML and High-Risk MDS [Recruiting]
Phase II Study of Clofarabine in Pediatric Acute Lymphoblastic Leukemia (ALL) [Completed]
Phase II Study of Clofarabine in Pediatric Acute Myelogenous Leukemia (AML) Patients [Completed]
Dose Escalation Study of Clofarabine in Patients With Relapsed or Refractory Low Grade or Intermediate-Grade B-Cell Lymphoma [Recruiting]
Phase II Study of Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia [Completed]
A Phase I Trial of Myeloablative Conditioning w/ Clofarabine and HD Busulfan for Pts w/ Refractory Heme Malignancies Undergoing Allo PBSCT [Recruiting]
Phase I Trial of Clofarabine in Combo w/ HD Etoposide & Cyclophosphamide and APBSCT for Pts w/ High-Risk or Refractory NHL [Recruiting]
Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma [Recruiting]
Study of Clofarabine & Cytosine Arabinoside Therapy for Older Adults With Acute Myeloid Leukemia [Recruiting]
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia [Recruiting]
A Study of Oral Clofarabine in Adult Patients With Myelodysplastic Syndromes (MDS) [Recruiting]
A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I) [Recruiting]
Clofarabine Bone Marrow Cytoreduction [Recruiting]
A Study of Clofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute Leukemias. [Recruiting]
Investigation of Clofarabine in Acute Leukemias [Active, not recruiting]
Clofarabine and Gemtuzumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Recruiting]
Busulfan, Fludarabine, Clofarabine With Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia [Recruiting]
Clofarabine, Cytarabine, and G-CSF in Treating Patients With Myelodysplastic Syndromes [Recruiting]
Phase I/II Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen [Recruiting]
Clofarabine in Chronic Lymphocytic Leukemia [Active, not recruiting]
A Non-Myeloablative Conditioning Regimen for Allogeneic Transplantation With Clofarabine, Cytarabine, and Thymoglobulin for Myelodysplastic Syndrome and Acute Myeloid Leukemia [Recruiting]
Clofarabine, Cytarabine, and G-CSF in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Recruiting]
Clofarabine and Cyclophosphamide Combination in Acute Lymphoblastic Leukemia Patients [Recruiting]
Clofarabine and Temsirolimus in Treating Older Patients With Relapsed or Refractory Acute Myeloid Leukemia [Recruiting]
Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia [Not yet recruiting]
A Phase II Study of Clofarabine in Patients With Relapsed or Refractory Multiple Myeloma [Completed]
A Phase II Study of Clofarabine in Patients With Aggressive Non-Hodgkin's Lymphoma [Active, not recruiting]
Cytarabine and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia [Recruiting]
Reduced Intensity AlloTransplant For Osteopetrosis [Terminated]
Clofarabine Plus Cytarabine in Patients With Previously Untreated Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome [Completed]
Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative Disorders [Recruiting]
Clofarabine in Treating Patients With Relapsed or Refractory T-Cell or B-Cell Non-Hodgkin's Lymphoma [Recruiting]
Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment [Recruiting]
Clofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Myelodysplastic Syndromes [Recruiting]
Cytarabine and Clofarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia [Recruiting]
Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease [Recruiting]
HSCT for High Risk Inherited Inborn Errors [Recruiting]
Clofarabine, Melphalan, and Alemtuzumab Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Diseases [Recruiting]
Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Leukemia [Recruiting]
Clofarabine for Relapsed or Refractory T-Cell or B-Cell Non-Hodgkin Lymphoma (NHL) [Recruiting]
Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant [Recruiting]
Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies [Recruiting]
Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes [Recruiting]
Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia [Recruiting]
NK Cell Transplantation for AML [Recruiting]
Quality of Life of Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS) [Recruiting]
|
